Investor
Relations

ILA
148.8
Last Update
July 23, 2024 3:41 PM
Pricing Delayed by 20 Minutes
Stock Information Provided by Google Finance

Recent years have been characterized by accelerated growth, including the establishment of two additional divisions besides the Logistics Division, and acquisitions of companies that developed a service or technology that is relevant to the operations of these divisions.

Today, Novolog is a leading healthcare services group in Israel, which employs 1000 employees, provides service to all public and private medical entities in Israel, operates national healthcare projects for the Israeli Ministry of Health and serves as a strategic partner of international pharma companies operating in Israel

Novolog has been a publicly-traded company on the Tel-Aviv Stock Exchange since 2017 and is currently listed on the Tel-Aviv 125 Index. We at Novolog are continuing to be alert and attentive to global trends in the healthcare sector and develop technology-based solutions and services in order to improve the healthcare sector in Israel – professionally and responsibly.

Quarterly Results

300+

Lorem ipsum dolor sit amet

4.3M

Lorem ipsum dolor sit amet

₪712M

Lorem ipsum dolor sit amet

28

Lorem ipsum dolor sit amet

FY21 Revenue

$123,456M Total

Lorem ipsum dolor sit amet, consectetur adipiscing: $2,034

Lorem ipsum dolor sit amet, consectetur adipiscing: $1,020

This is some text inside of a div block.

FY21 Revenue

$123,456M Total

Lorem ipsum dolor sit amet, consectetur adipiscing: $2,034

Lorem ipsum dolor sit amet, consectetur adipiscing: $1,020

This is some text inside of a div block.

Intermediate Reports

March 27, 2024
June 30, 2024

In March 26th 2024, the company announced distribution of dividend in the amount of NIS 15 million

March 6, 2024
June 30, 2024

Novolog anticipates a projected loss in Q4 2023 of 47 to 57 million NIS

June 27, 2023
October 15, 2023

Aviad Busi joins Novolog as CEO of Novolog Group

Press Releases

March 6, 2024
June 30, 2024

The publication date for the financial statements of 2023 is March 26th, 2024, with a conference meeting scheduled for the same date at 1:00 PM

April 18, 2023
April 19, 2023

Eran Taus, the CEO of Novolog, has announced that he will be stepping down from his position after six years

December 21, 2021
March 10, 2022

Preliminary medical inquiries, without human contact

Novolog Group’s Digital Division, together with the startup Kahun, are currently launching “Symptomi”